Mr. Speaker, as I said, we have and will continue to take action on tax avoidance and tax evasion, but it is nice that the members opposite are bringing up pharmacare, because we recognize on this side of the House that Canadians pay too much for prescription drugs, and our government is taking bold action now to bring down prices. We joined the provinces and territories as a member of the pan-Canadian Pharmaceutical Alliance, which negotiates lower drug prices on behalf of public drug plans. Through budget 2017, we are investing over $140 million to help improve access to pharmaceuticals and to support innovations within the health care system. We are going to continue to ensure that Canadians can better afford the—
In the House of Commons on February 13th, 2018. See this statement in context.